First, it promotes tumour growth through the AKT and ERK1/2 signalling pathways (9, 42) and activation of the CARMA3-Bcl10-MALT1(CBM) signalling complex, which then induces NF-κB production (43). The gene discussed is NFKB1; the disease is neoplasm.